Argos Therapeutics reports results from phase IIb trial of AGS-004 in HIV-1 infection Jan. 12, 2015 No Comments
Janssen and Gilead amend and expand HIV single-tablet regimen development agreements Dec. 31, 2014 No Comments
ViiV Healthcare applies for Japanese approval of dolutegravir/abacavir/lamivudine Dec. 16, 2014 No Comments